ABVC BioPharma, Inc. Common Stock (ABVC)
ABVC BioPharma, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for medical conditions such as neurological, psychiatric, and oncological disorders. The company leverages its expertise in biotechnology to advance drug discovery and development, with a particular emphasis on integrating traditional and modern medicine approaches. Headquartered in the United States, ABVC aims to address unmet medical needs through its pipeline of investigational therapies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 4, 2013 | $0.29 | 2013-09-16 | 2013-09-18 |
| April 4, 2013 | $0.04 | 2013-03-06 | 2013-03-08 |
| April 4, 2013 | $0.28 | 2013-03-06 | 2013-03-08 |
| January 29, 2013 | $0.40 | 2012-12-27 | 2012-12-31 |
| January 29, 2013 | $0.05 | 2012-12-27 | 2012-12-31 |
Dividends Summary
- ABVC BioPharma, Inc. Common Stock has issued 57 dividend payments over the past 10 years
- The most recent dividend was paid 4403 days ago, on October 4, 2013
- The highest dividend payed out to investors during this period was $1.65 per share
- The average dividend paid during this period was $0.31 per share.
Company News
FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that the Company's subsidiary AiBtl BioPharma Inc. acquired TT...
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance. For the fourth quarter, the company expects revenue of $634 million-$638 million (vs. $636.39 million) and adjusted operating income of $241 million-$247 million. The compan...
Use these tips for finding cheap penny stocks to buy The post How to Find Cheap Penny Stocks to Make Money Trading appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The Securities and Exchange Commission has filed a lawsuit against eight individuals who allegedly earned $100 million via stock manipulation.